Cancer Options Blog

This blog is a way of sharing, supporting and educating anyone dealing with a cancer-related illness about the options and treatments they have at their disposal.

You're browsing: Home » Blog » Coping with Cancer, News » Blog article: High fat diet may abet prostate cancer progression

High fat diet may abet prostate cancer progression

This Article was Written July 3rd, 2008

Powered by Gregarious (39)

By Joene Hendry

NEW YORK (Reuters Health) - Diets high in saturated fat may increase the risk of prostate cancer progression, researchers from the University of Texas M. D. Anderson Cancer Center in Houston report.

In a follow up study of men who had their cancerous prostates removed, researchers found that men who consumed higher amounts of saturated fat — mostly from steaks, burgers, cheese, ice cream, salad dressings, and mayonnaise — were nearly two times more likely to experience disease progression after surgery than men with lower saturated fat intake.

“Diet before surgery, especially saturated fat, may modulate patient outcome after surgery,” Dr. Sara S. Strom, who was involved in the study, told Reuters Health.

Strom and colleagues also found significantly shorter “disease-free” survival times among obese men who ate high amounts of saturated fat compared with non-obese men consuming diets low in saturated fat.

These results expand upon the team’s previous finding linking obesity with prostate cancer progression “and suggest that saturated fat intake plays a role in prostate cancer progression,” the researchers note in the International Journal of Cancer.

Strom’s group used standard food questionnaires to assess the saturated fat intake of 390 men during the year before surgery for localized, or “organ-confined” prostate cancer. The researchers also assessed the men’s medical and family history for other risk factors for disease progression.

The men, all Caucasian, were about 60 years old on average and consumed between 600 and 5,000 calories daily. Overall, 293 men averaged 10 percent of their daily energy from saturated fat (low intake) while 97 men averaged 14 percent (high intake).

Obese men with a high saturated fat intake had the shortest survival time free of prostate cancer (19 months), while non-obese men with low intake survived the longest time free of the disease (46 months).
Non-obese men with high intake and obese men with low intake had “disease-free” survival of 29 and 42 months, respectively, the researchers report.

Additional investigations looking at associations between post-surgery dietary changes and disease progression would be worthwhile, Strom suggests.

SOURCE: International Journal of Cancer, June 1, 2008

For information regarding prostate cancer treatment options, please visit www.proxcelan.com

Powered by Gregarious (39)

PLEASE post a comment below

  • Categories

  • Subscribe

    All posts by all authors Google Reader or Homepage Subscribe Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online Add to My AOL Subscribe in Rojo Add to Technorati Favorites!
    Business Blogs - BlogCatalog Blog Directory

    Enter your email address:

    Comments (RSS)

  • Random Posts & Pages

    Why Some Prostate Cancer Returns

  • Why Some Prostate Cancer Returns The majority of men who receive one of the standard treatments for localized prostate cancer - surgery or radiation therapy - have an excellent outcome.But for the small group whose prostate cancer returns, a new study offers insight as to why treatment isn't effective. The study -
  • Brachytherapy of prostate cancer treatment and sterility

  • Posted: Sep 27th, 2009 | We'll talk about the relationship between Brachytherapy of prostate cancer treatment and sterility.Brachytherapy radiation through a direct effect or through indirect effects of free radicals was generated to destroy the DNA double-strand,Instead of splitting the tumor cells can survive longer.Generally cells in M phase and
  • Legal Notices

  • IsoRay Medical, Inc. Website Terms Of Use Agreement And Disclaimer Of Liability Welcome to www.isoray.com (the “Website”). IsoRay Medical, Inc. and its affiliates (“we,” “us” or “IsoRay”) provide the information and content on this Website as a convenience and for general informational and educational purposes only. By accessing this Website, you, and any parties
  • All About Robot-Assisted Prostate Surgery

  • What Should You Know About FascinatingTreatment Option?By Matthew Schmitz, M.D., About.com GuideCreated: November 19, 2009About.com Health's Disease and Condition content is reviewed by the Medical Review BoardRobot-assisted prostate surgery is a relatively new treatment option for prostate cancer. So what do you need to know about this fascinating surgical option?How Does Robot-Assisted Prostate
  • Newest isotope used in brachytherapy for prostate cancer

  • FOR IMMEDIATE RELEASE: July 20, 2007 Scientific abstracts on the newest isotope used in brachytherapy for prostate cancer--IsoRay Medical’s Proxcelan™ with Cesium-131--presented at the American Association of Physicists in Medicine (AAPM) annual conference, July 22-26 RICHLAND, Washington - Noted medical researchers from around the country will gather at the
  • ASTRO’s 49th annual meeting of radiation oncology

  • ProxcelanTM (Cesium-131) is the newest advancement in permanent brachytherapy seed implants for prostate cancerLOS ANGELES, CA - Several newly released scientific findings focusing on various aspects of ProxcelanTM (Cesium-131) seeds' effectiveness in the treatment of prostate cancer--supporting and broadening the growing body of evidence on the newest medical isotope being
  • Are Prostate Needle Biopsies Predictive Of The Laterality Of Significant Cancer And Positive Surgical Margins?

  • Are Prostate Needle Biopsies Predictive Of The Laterality Of Significant Cancer And Positive Surgical Margins? UroToday.com - In the online edition of the British Journal of Urology International, Dr. Rodrigo Frota presents the single surgeon laparoscopic radical prostatectomy (LRP) experience of Dr. Inderbir Gill. The study is a retrospective review with the intent
  • Proxcelan™ with Cesium-131 advantages

  • Proxcelan™ (Cesium-131) brachytherapy seeds offer patients unique advantages over other medical isotopes. Increasingly, prostate cancer patients and their doctors who decide on seed brachytherapy choose Cesium-131 treatment because of its significant advantages over Palladium-103 and Iodine-125, two other isotopes currently in use. These advantages include Higher Energy, Shorter Half-Life,
  • Strikeout prostate cancer

  •  About one in six men is diagnosed with prostate cancer. If it's caught early, the cancer is almost 100-percent curable, but if it goes undetected, it can be deadly. So now a new campaign is raising money and getting guys attention . . . with America's favorite pasttime. As major league
  • Diet Modification Slows PSA Doubling After Prostate Cancer Treatment

  • Diet Modification Slows PSA Doubling After Prostate Cancer Treatment   NEW YORK JAN 29, 2009 (Reuters Health) - A diet low in saturated fat, high in vegetable protein and low in animal protein is associated with a "substantial" increase in prostate-specific antigen (PSA) doubling time and an increase in quality of life in


  •  

    March 2010
    M T W T F S S
    « Jan    
    1234567
    891011121314
    15161718192021
    22232425262728
    293031